| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/JVI.00605-08 |
| P8608 | Fatcat ID | release_q7ndq46b6rhuvfutotcy33az44 |
| P932 | PMC publication ID | 2493338 |
| P698 | PubMed publication ID | 18508902 |
| P5875 | ResearchGate publication ID | 5341863 |
| P50 | author | Barton Haynes | Q4865631 |
| Thomas Denny | Q42939171 | ||
| Guido Ferrari | Q56481169 | ||
| M Anthony Moody | Q73297881 | ||
| George M. Shaw | Q78514357 | ||
| Kent J. Weinhold | Q109935303 | ||
| Janet S Ottinger | Q114419529 | ||
| Steven G Plonk | Q114419533 | ||
| Nancy Gasper-Smith | Q125314797 | ||
| P2093 | author name string | Li Qin | |
| Sara E Miller | |||
| Laura E Jones | |||
| John F Whitesides | |||
| David S Pisetsky | |||
| Charles F Reich | |||
| Nadia Mensali | |||
| Deanna M Crossman | |||
| Stephen G Self | |||
| P2860 | cites work | Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention | Q21245029 |
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract | Q22242981 | ||
| Exosomes with immune modulatory features are present in human breast milk | Q24321270 | ||
| Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection | Q27480421 | ||
| Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection | Q27486378 | ||
| Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation | Q28344659 | ||
| Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection | Q29619099 | ||
| Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection | Q29619124 | ||
| Circulating microparticles: pathophysiology and clinical implications. | Q33373336 | ||
| Clinical picture of primary HIV infection presenting as a glandular-fever-like illness | Q33447605 | ||
| Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l | Q33849293 | ||
| CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little | Q33884028 | ||
| Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. | Q33984320 | ||
| Mechanisms of HIV-associated lymphocyte apoptosis | Q34069516 | ||
| Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection | Q34228730 | ||
| Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. | Q34332663 | ||
| RETRACTED: Pregnancy-associated exosomes and their modulation of T cell signaling | Q34486229 | ||
| Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo | Q34554352 | ||
| An HIV vaccine--evolving concepts | Q34629012 | ||
| Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. | Q35020357 | ||
| TRAIL-mediated apoptosis in HIV-1-infected macrophages is dependent on the inhibition of Akt-1 phosphorylation | Q35842625 | ||
| CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis | Q35847699 | ||
| Viral proteins targeting mitochondria: controlling cell death | Q35970213 | ||
| Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients | Q36180409 | ||
| Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection | Q36225040 | ||
| Perils at mucosal front lines for HIV and SIV and their hosts | Q36274922 | ||
| Viral dynamics of acute HIV-1 infection | Q36375339 | ||
| Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. | Q36380292 | ||
| Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. | Q36471285 | ||
| Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239. | Q36540014 | ||
| Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy | Q36541079 | ||
| Clearance of apoptotic and necrotic cells and its immunological consequences | Q36585103 | ||
| HIV-1 immunopathogenesis: how good interferon turns bad. | Q36656715 | ||
| Microparticles as mediators of cellular cross-talk in inflammatory disease | Q36687910 | ||
| IL-10, T cell exhaustion and viral persistence | Q36750429 | ||
| The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection | Q37365561 | ||
| Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection | Q39200565 | ||
| Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. | Q39412581 | ||
| Differential mechanisms of microparticle transfer toB cells and monocytes: anti-inflammatory propertiesof microparticles | Q40316213 | ||
| Hepatitis B virus immunopathogenesis | Q40444875 | ||
| Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. | Q40460735 | ||
| Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells | Q40764496 | ||
| Apoptosis-inducing membrane vesicles. A novel agent with unique properties | Q42825776 | ||
| Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice | Q42944373 | ||
| TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex | Q43925949 | ||
| Antibody response in primary human immunodeficiency virus infection | Q44009472 | ||
| Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection | Q45420228 | ||
| Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons. | Q45752978 | ||
| Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters | Q45783344 | ||
| Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection | Q45786097 | ||
| Antibody response to human immunodeficiency virus after primary infection | Q45830789 | ||
| High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection | Q45854355 | ||
| Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection | Q45856562 | ||
| Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system | Q47756393 | ||
| Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. | Q51993308 | ||
| TRAIL/Apo-2-ligand-induced apoptosis in human T cells. | Q54146049 | ||
| Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia | Q58621898 | ||
| Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2 | Q60193080 | ||
| TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells | Q61312703 | ||
| Measuring circulating cell-derived microparticles | Q62977671 | ||
| Clinical and epidemiologic features of primary HIV infection | Q71182378 | ||
| High plasma level of soluble tumor necrosis factor receptor type II (sTNFRII) in asymptomatic HIV-1-infected patients | Q71542182 | ||
| HIV-1-induced depletion of CD4+ T cells in the gut: mechanism and therapeutic implications | Q81595423 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine engineering | Q14861085 |
| HIV transmission | Q49029021 | ||
| P304 | page(s) | 7700-7710 | |
| P577 | publication date | 2008-05-28 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design | |
| P478 | volume | 82 |
| Q34185814 | Acute HIV-1 Infection |
| Q33794973 | Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines |
| Q27342233 | Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline |
| Q34645502 | B cell responses to HIV-1 infection and vaccination: pathways to preventing infection |
| Q34633003 | CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis |
| Q34284335 | CLEC-2 expression is maintained on activated platelets and on platelet microparticles. |
| Q38892529 | Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes |
| Q37543416 | Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport |
| Q55421347 | Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection. |
| Q38077245 | Coxsackievirus B transmission and possible new roles for extracellular vesicles. |
| Q38114911 | Dendritic cell dysregulation during HIV-1 infection |
| Q35790117 | Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysis |
| Q37033383 | Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection |
| Q35363127 | Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection |
| Q38103193 | Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis |
| Q36228320 | Elevated Abundance, Size, and MicroRNA Content of Plasma Extracellular Vesicles in Viremic HIV-1+ Patients: Correlations With Known Markers of Disease Progression |
| Q33576664 | Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection |
| Q37535237 | Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro |
| Q35274776 | Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection |
| Q55277536 | Granulocyte-Derived Extracellular Vesicles Activate Monocytes and Are Associated With Mortality in Intensive Care Unit Patients. |
| Q34952914 | HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection |
| Q36874604 | HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. |
| Q36498061 | HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44 |
| Q33951949 | HIV/SIV infection primes monocytes and dendritic cells for apoptosis. |
| Q35922101 | HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells |
| Q37301445 | Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection |
| Q38000415 | IFN-α and TRAIL: a double edge sword in HIV-1 disease? |
| Q33992829 | Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? |
| Q27488278 | Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections |
| Q34848486 | Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia |
| Q51743758 | Innate immunity in HIV infection and implications for vaccine design: a summary of the workshop held at the National Institute of Allergy and Infectious Diseases, Bethesda on February 25-26, 2010. |
| Q37653075 | Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses. |
| Q37734746 | Microbial TLR Agonists and Humoral Immunopathogenesis in HIV Disease |
| Q37015889 | Microbial Translocation and B Cell Dysfunction in Human Immunodeficiency Virus Disease |
| Q37581155 | Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Ex vivo. |
| Q37409983 | Modern uses of electron microscopy for detection of viruses |
| Q45350854 | Multi-functional plasmacytoid dendritic cells redistribute to gut tissues during simian immunodeficiency virus infection |
| Q42221741 | NKT cell depletion in humans during early HIV infection |
| Q57095865 | Natural SIV Infection |
| Q40932064 | Plasmacytoid dendritic cells: the novel Eldorado for antiviral therapy? |
| Q33479167 | Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection |
| Q30374995 | Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia. |
| Q34612821 | Role of the Fas/FasL pathway in HIV or SIV disease |
| Q35232811 | Simple mathematical models do not accurately predict early SIV dynamics |
| Q36162133 | Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development |
| Q42273481 | T-Cell Signaling in HIV-1 Infection |
| Q37333743 | T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces |
| Q35200862 | The acute HIV infection: implications for intervention, prevention and development of an effective AIDS vaccine |
| Q37273195 | The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection |
| Q34614862 | The immune response during acute HIV-1 infection: clues for vaccine development |
| Q34193462 | Three-dimensional microscopy characterization of death receptor 5 expression by over-activated human primary CD4+ T cells and apoptosis |
| Q33680395 | Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing |
| Q34874985 | Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients |
| Q37295142 | Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus |
Search more.